Latest Advances in Lung Cancer Research

Chest CT scans used for lung cancer screening can do more than just find early lung cancer. These scans can also detect heart problems and early emphysema, offering a three-in-one health check for people at risk.

Oncologists have discovered that difficulties treating and managing the most common type of lung cancer, adenocarcinoma or non-small cell lung cancer, is related to a protein called agrin.

A study of over 10,000 people showed that sticking with regular lung cancer screening leads to better detection of early-stage cancer. However, fewer people returned for follow-up screenings each year.

Researchers at Johns Hopkins Medicine have developed an innovative computer model that could significantly improve immunotherapy outcomes for lung cancer patients.

The study highlights that the timing of irAEs depends on the specific immunotherapy and recent treatment history.

New research separates the effects of smoking, environment, genetics, and healthcare access on lung cancer mortality, providing insights for better prevention strategies.

Early detection of incidental lung nodules can lead to timely treatment and improved survival rates for lung cancer patients.

New hope for small cell lung cancer patients as the first patient receives Peluntamig in a clinical trial. This experimental drug targets specific cancer growth pathways.

New blood test using ctDNA methylation biomarkers shows promise for early lung cancer detection, potentially improving treatment outcomes for patients.

New drug shrinks HER2-mutant lung cancer tumors in 73% of patients, offering hope for improved treatment options.

Increasing lung cancer cases in non-smokers highlight the need for research into causes and improved detection methods

UC Davis Health introduces cutting-edge CT imaging technology that detects smaller lung tumors with less radiation, improving early detection and treatment planning.